EMA Starts ‘Rolling Review’ Of AstraZeneca’s COVID-19 Vaccine

The European Medicines Agency says its rolling review tool should speed up the evaluation of AstraZeneca’s COVID-19 vaccine.

A single bottle vial of Covid-19 coronavirus vaccine in a research medical lab. 3D illustration.
The EMA has begun the first rolling review for a COVID-19 vaccine • Source: Shutterstock

The European Medicines Agency has started a rolling review of the COVID-19 vaccine that AstraZeneca is developing with the University of Oxford.

Given that much of the evidence on the vaccine – which the EMA refers to as COVID-19 Vaccine AstraZeneca (AZD1222)...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet